Eli Lilly increases dividends
Novo Nordisk competitor Eli Lilly will increase the dividends it pays out by 15%.
by marketwire, translated by catherine brett
US pharma giant Eli Lilly, which competes with Novo Nordisk within the obesity and diabetes indications, has decided to increase its dividend payouts by 15% to USD 1.13 per share, it reports.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
